HMGB1 and neoplasm: Briefly, tumor cells undergoing ICD expose calreticulin (CRT) on the outer leaflet of the cell membrane, secreting adenosine triphosphate (ATP) and releasing high mobility group box 1 (HMGB1) into extracellular microenvironment (29, 30, 86).